-
(E)-7-((1R,2R,3R)-3-Hydroxy-2-((3S,5S,E)-3-hydroxy-5-methylnon-1-en-1-yl)-5-oxocyclopentyl)hept-2-enoic acid
-
BD13634674397-12-998%
-
¥1329.05mg
-
N-(3-(5-(2-Hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyrimidine-5-carboxamide
-
BD6300351234708-04-398%
-
¥4950.010mg
-
2-(3,4-Dimethoxyphenyl)-5,6,7-trimethoxy-4H-chromen-4-one
-
BD12062306-27-695%
-
¥964.010mg
-
2-Hydroxy-4H-benzo[d][1,3,2]dioxabismin-4-one
-
BD11739614882-18-998%
-
¥50.025g
-
4-(Benzo[b]thiophen-2-yl)-3-bromo-5-hydroxyfuran-2(5H)-one
-
BD427318938069-71-798%
-
¥2000.0100mg
-
14-Methyl-5-oxo-7,8-dihydro-5H-indolo[2',3':3,4]pyrido[2,1-b]quinazolin-14-ium-13-ide
-
BD20826167909-49-399%
-
¥437.0100mg
-
1-(4-(2H-Tetrazol-5-yl)butyl)-4-(5H-dibenzo[a,d][7]annulen-5-ylidene)piperidine
-
BD305637162640-98-498+%
-
¥437.025mg
-
(S)-2-(2-Fluoro-[1,1'-biphenyl]-4-yl)propanoic acid
-
BD2115051543-39-698%
-
¥1792.0250mg
-
2-(2-Fluoro-[1,1'-biphenyl]-4-yl)propanoic acid
-
BD1306425104-49-498%
-
¥184.010g
-
(E)-3-(3,5-di-tert-butyl-4-hydroxybenzylidene)dihydrofuran-2(3H)-one
-
BD01137239102271-49-898%
-
¥1481.050mg
-
14-Methyl-8,14-dihydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one hydrochloride
-
BD298331111664-82-595%
-
¥502.0100mg
-
HPGDS inhibitor 1
-
BD2171611033836-12-298%
-
¥1327.0100mg
-
2-(5H-Chromeno[2,3-b]pyridin-7-yl)propanoic acid
-
BD3392552549-17-498%
-
¥1704.05g
-
Desoxo-narchinol A
-
BD0146490353859-06-698%
-
¥1562.01mg
-
1-(3-(1H-Tetrazol-5-yl)propyl)-4-(benzhydryloxy)piperidine
-
BD91286162641-16-997%
-
¥7807.050mg
-
UT-11
-
BD0228412398%
-
¥
-
PROTAC(H-PGDS)-7
-
BD015293632761281-50-798%
-
¥
-
7-((1R,2R,3R)-3-Hydroxy-2-((3S,5S)-3-hydroxy-5-(methyl-d3)non-1-en-1-yl)-5-oxocyclopentyl)hept-2-enoic acid
-
BD011647791263190-37-998% 98%atom%D
-
¥
-
1-(5-Chloro-6-(4-chlorophenyl)benzo[d]oxazol-2-yl)-N-((1S,3S)-3-(hydroxymethyl)cyclohexyl)piperidine-4-carboxamide
-
BD011400261312815-93-298+%
-
¥7512.025mg